A research team from the University of Minnesota recently received a five -year subsidy of $ 3.8 million from the American National Institutes of Health to develop a new cell therapy to combat Alzheimer’s disease. More than 55 million people worldwide live with dementia, including Alzheimer’s disease and other related disorders.
The project is intended to adjust advanced techniques that have been developed for the treatment of cancer to create specialized macrophages – immune cells that can surround and remove proteins from their environment – to find and erase harmful proteins in the brain.
Manipulated immune cells have shown a remarkable promise in the treatment of cancer. We hope to make use of these progress to develop an effective new way to treat Alzheimer’s disease. “
Beau Webber, PhD, assistant professor at the University of Minnesota Medical School and a researcher from Masonic Cancer Center
The team will develop genetic human stem cells that are re -programmed from adult cells before being converted into a specialized immune cell type to focus on toxic toxic tou -proteins, an important engine of Alzheimer’s disease. The cells will also be designed to arrange inflammation, which is a major challenge in the treatment. This innovative approach could pave the way for a scalable, subsequent generation of therapy to delay or stop the progression of Alzheimer’s.
“The success of our team in collecting nih funds for this exciting new technology emphasizes the impact of collaborations between the medical school and the College of Science and Engineering. We are delighted to innovate in various disciplines to design breakthrough therapies with the potentially biomen,” said Jonataning, “said Jonathing,” Jonathing, “said Jonathing,” Jonatd, “Jonathed,” Jonathed, “Jonathed,” Jonathed, “Jonathed,” Jonathed, “Jonathed,” Jonathed, “Jonathes,” Jonathes, “Jonathed,” Jonathed, “Jonathes,” Jonathed, “Jonathes,” Jonathes -Professor in the University of Minnesota Minnes and Engineering.
The project officially started in January.